Research ArticleBrief Communication
Open Access
Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study
Joanne E. Mortimer, James R. Bading, Paul H. Frankel, Mary I. Carroll, Yuan Yuan, Jinha M. Park, Lusine Tumyan, Nikita Gidwaney, Erasmus K. Poku, John E. Shively and David M. Colcher
Journal of Nuclear Medicine August 2022, 63 (8) 1145-1148; DOI: https://doi.org/10.2967/jnumed.121.262940
Joanne E. Mortimer
1Department of Medical Oncology and Experimental Therapeutics, City of Hope, Duarte, California;
James R. Bading
1Department of Medical Oncology and Experimental Therapeutics, City of Hope, Duarte, California;
Paul H. Frankel
2Department of Information Sciences, City of Hope, Duarte, California;
Mary I. Carroll
1Department of Medical Oncology and Experimental Therapeutics, City of Hope, Duarte, California;
Yuan Yuan
1Department of Medical Oncology and Experimental Therapeutics, City of Hope, Duarte, California;
Jinha M. Park
3Department of Radiology, City of Hope, Duarte, California; and
Lusine Tumyan
3Department of Radiology, City of Hope, Duarte, California; and
Nikita Gidwaney
3Department of Radiology, City of Hope, Duarte, California; and
Erasmus K. Poku
4Department of Cancer Molecular Imaging and Therapy, Beckman Research Institute of the City of Hope, Duarte, California
John E. Shively
4Department of Cancer Molecular Imaging and Therapy, Beckman Research Institute of the City of Hope, Duarte, California
David M. Colcher
4Department of Cancer Molecular Imaging and Therapy, Beckman Research Institute of the City of Hope, Duarte, California
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue 8
August 1, 2022
Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study
Joanne E. Mortimer, James R. Bading, Paul H. Frankel, Mary I. Carroll, Yuan Yuan, Jinha M. Park, Lusine Tumyan, Nikita Gidwaney, Erasmus K. Poku, John E. Shively, David M. Colcher
Journal of Nuclear Medicine Aug 2022, 63 (8) 1145-1148; DOI: 10.2967/jnumed.121.262940
Use of 64Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study
Joanne E. Mortimer, James R. Bading, Paul H. Frankel, Mary I. Carroll, Yuan Yuan, Jinha M. Park, Lusine Tumyan, Nikita Gidwaney, Erasmus K. Poku, John E. Shively, David M. Colcher
Journal of Nuclear Medicine Aug 2022, 63 (8) 1145-1148; DOI: 10.2967/jnumed.121.262940